Added to YB: 2025-07-30
Pitch date: 2025-07-28
PAX.ST [bullish]
Paxman AB (publ)
-33.09%
current return
Author Info
Healthy Stock Picks focuses on the global healthcare sector. Sign up for the newsletter.
Company Info
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide.
Market Cap
SEK 1.8B
Pitch Price
SEK 82.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
33.63
P/E
73.73
EV/Sales
5.98
Sector
Health Care Equipment and Supplies
Category
growth
Paxman - $PAX.ST
PAX.ST: Scalp cooling device prevents chemo-induced hair loss, improving cancer patient experience. US reimbursement improving, acquired main competitor in 2025 creating near-monopoly. Growth depends on increasing utilization of installed machines. Attractive microcap with both short-term catalyst and long-term compounding potential.
Read full article (3 min)